Many inherited metabolic diseases are caused by specific enzyme deficiencies. However, among diseases characterized by the same enzyme deficiency, many variants exist with diverse clinical manifestations. Frequently, heterokaryons formed by fusing cultured cells from these variants showed complementation of the previously deficient enzyme activity, indicating that the genetic defects in these variants were not identical although the biochemical manifestations were apparently the same. Complementation groups have been found among the variants of GM1 gangliosidosis (1), the mucopolysaccharidoses (2), xeroderma pigmentosum (3), methylmalonicacidemia (4) , galactosemia (5) , and the GM2 gangliosidoses, Tay-Sachs and Sandhoff diseases (6) (7) (8) . The lack of proper selection medium, however, precluded the isolation of somatic cell hybrids from these heterokaryons for more precise identification of the complemented enzyme and further biochemical and genetic studies.
A nonselective method to circumvent the above limitation in isolating euploid human somatic hybrid clones was recently developed (9) . It depended on separating a fusogen-treated mixture of two fibroblast strains according to size by unitgravity sedimentation. The fractions highly enriched with double-nucleated cells were cloned to isolate the hybrid cells. Hybrids were identified by karyotyping and by an enzyme polymorphism characteristic of the two parent cell strains. This technique was applied to study the genetic defects of two inborn errors of metabolism, metachromatic leukodystrophy (MLD) and its O-variant, multiple sulfatase deficiency disorder (MSDD) .
Hereditary metabolic diseases have been useful in providing answers to important basic genetic questions. MLD and MSDD are severe neurodegenerative diseases both characterized by a deficiency of arylsulfatase A (ARSA; aryl-sulfate sulfohydrolase, EC 3.1.6.1) activity although they are inherited as separate autosomal recessive traits. They have similar clinical symptoms but can be differentiated by subtle differences, such as the presence of Alder-Reilly granules in leukocytes (10) and the accumulation of glycosaminoglycans in addition to cerebroside sulfates in patients with MSDD (11) . In MLD, only ARSA activity is affected, but in MSDD, deficiencies of other arylsulfatases occur-i.e., arylsulfatase B (ARSB), arylsulfatase C (ARSC), and steroid sulfatases (11) (12) (13) (14) . This raised a number of questions. What is the nature of the genetic defects involved such that two distinct diseases are deficient in the same enzyme activity? Are they due to allelic or nonallelic mutations? Furthermore, how does a single genetic defect in MSDD diminish the biochemical activity of so many apparently unrelated enzymes? Answers to these questions were sought by looking for complementation of ARSA activity in hybrid clones formed between cultured skin fibroblasts from MLD and MSDD patients followed by further definition of the nature of such complementation biochemically and immunologically.
MATERIALS AND METHODS' Cell Culture. Cultured skin fibroblasts from a patient with the juvenile form of MLD were supplied by J. A. Lowden (Hospital for Sick Children, Toronto, Ontario); those from a patient with MSDD were supplied by H. Kihara (University of California, Los Angeles, CA). Skin fibroblasts for controls were obtained from patients with normal karyotypes and no known metabolic disease. Fibroblasts were maintained in Ham's F-10 culture medium supplemented with L-glutamine (2 mM) and 10-20% (vol/vol) fetal calf serum under 5% CO2 in air and 100% humidity at 370C. Penicillin (100 units/ml) and streptomycin (100 ,ug/ml) were included in the culture medium during experiments.
Nonselective Isolation and Identification of Hybrids. Hybrid somatic cell clones were produced by fusion of fibroblasts with polyethylene glycol 1000 (15) and isolation by unit-gravity sedimentation as described by Chang et al. (9) .
Karyotyping was performed in situ on cells grown on cov- 
RESULTS

Isolation of hybrid clones
After cultured skin fibroblasts from MLD and MSDD patients were fused and separated by unit-gravity sedimentation, 123 clones were successfully identified by karyotyping. Of these, 86 were diploid, 12 were mixed diploid and tetraploid, and 25 were pure tetraploid clones.
The origin of the tetraploid clones was established by the PGM1 electrophoretic mobility on Cellogel. The MLD fibroblasts had PGM11 and the MSDD fibroblasts had PGM12. Five of the tetraploid clones were found to have the PGM11 pattern (homologous MLD fusion), 17 had the PGM12 pattern (homologous MSDD fusion), and 3 had the hybrid PGM12-1 pattern expected from a fusion between MLD and MSDD cells. Al PGM1 patterns in the tetraploids were confirmed again after 6-11 passages in culture. Screening for ARSA activity in tetraploid clones The soluble arylsulfatase activities (ARSA and ARSB) of these tetraploid clones were monitored by Cellogel electrophoresis and by enzymatic assays on fibroblast extracts with 4-methylumbelliferylsulfate as substrate. ARSA migrated anodally during Cellogel electrophoresis and appeared as a bright fluorescent band when stained with 4-methylumbelliferylsulfate. This band was not seen in the MLD or MSDD diploid fibroblasts or in the tetraploid cells formed from homologous fusions. In the three hybrid tetraploid clones, however, a distinct band of activity corresponding to that of ARSA from a normal fibroblast strain appeared (Fig. 1) .
The quantitative assays of ARSA, ARSB, and ARSC activities of normal fibroblasts, the diploid MLD and MSDD parent cell strains, and their tetraploid clones that were vigorous enough to propagate in culture are shown in Table 1 . MLD cells had 15% of normal ARSA activity, whereas ARSB and ARSC were within normal range. In the single tetraploid clone from homologous fusion of MLD cells, the same enzyme activity pattern was maintained as in the parent diploid cells. In the MSDD diploid cells, only ARSB was within the normal range; ARSA and ARSC were about 25% of normal. In the five tetraploid clones from homologous fusion of MSDD cells, all three arylsulfatases showed increased activities. ARSA was about 50% of normal. ARSC reached normal levels, and ARSB attained almost 300% of the normal value. In the hybrid clone from the heterologous fusion of MLD and MSDD cells, the activity of ARSA reached normal levels; the activities of ARSB and ARSC were elevated similar to the MSDD self-fusion tetraploid. These quantitative results were confirmed in a separate experiment (data not shown).
Characterization of restored ARSA in hybrid clones
Heat Stability. The percentage of ARSA activity remaining after heating at 50, 55, 60, 65, and 700C for 10 min each in three different normal fibroblast cell strains and one hybrid clone is shown in Fig. 2 . The temperature at which 50% of the activity remained (T50) was 59.0 + 1.40C for the three normal cell strains and 60.00C for the hybrid clone.
Kinetics. pH optimum. The relative activity of ARSA in the hybrid clone at different pH values was compared with that of a normal fibroblast strain (Fig. 3) . The optimal pH for both hybrid and normal strains was identical. With acetate as the buffering ion, the highest activity observed was at pH 5.6 (range tested, 4.5-5.6). With maleate as the buffering ion, the highest activity was at pH 6.0 (range tested, 5.3-6.5).
Michaelis constant. The activity of ARSA at different concentrations (1-10 mM) of the substrate 4-methylumbelliferylsulfate was plotted for three different normal fibroblast strains Within the same experiment, the Km of the hybrid ARSA activity was usually about half of the normal value. Immunological Identification. Extracts from a normal fibroblast strain and the hybrid clone were electrophoresed and then treated with a partially purified preparation of antibody against ARSA. They were stained for arylsulfatase activity; both showed immunoprecipitated activity bands of identical electrophoretic mobility (Fig. 4a) . Under similar conditions, the MLD cells did not show any enzymatically active precipitin band, whereas the MSDD cells showed a weak trace of activity (Fig. 4b) . In the control, in which a normal rabbit serum was used instead of the anti-ARSA preparation, no bands of activity were observed in any of the cell extracts. The restored ARSA activity exhibited properties indistinguishable from the normal enzyme when tested for heat stability (Fig. 2) , optimal pH (Fig. 3) , and Km. Its electrophoretic mobility, as shown by Cellogel electrophoresis (Fig. 1) , and immunologic reactivity, as tested by immunoelectrophoresis on agar gel (Fig. 4) , were also similar to those of the normal enzyme. In assessing the heat stability of this enzyme, it was important to dialyze the samples thoroughly and to inactivate the enzyme over a range of temperatures in order to compute T5o, the temperature at which 50% of the activity remained.
DISCUSSION
If the heat stability were tested at only a single temperature, there was too much variation even among different normal cell strains to allow for unequivocal identification. In contrast, the T50 was a more consistent parameter (see Fig. 2 ).
Because heat stability is one of the most sensitive techniques for detection of structural changes among enzymes, the identical T50 in the normal and complemented ARSA enzymes strongly suggested that the restored enzyme was structurally normal. This was corroborated by the similarities in kinetic, electrophoretic, and immunologic properties of the normal and the complemented ASA activities. These data showed clearly that the criteria for intercistronic (24, 25) complementation were met in that a structurally normal ARSA was restored in hybrids formed between MSDD and MLD cells.
The detection of complementation between MLD and MSDD cells depended on the successful isolation of the hybrid clones. In unsorted mixtures of fused and unfused cells from previous fusion experiments involving MLD cells and two other MSDD cell strains, we failed to detect significant increases in ARSA activity. Absence of complementation between MLD and MSDD cells was also reported by workers in two other laboratories (14, 26) using similar techniques of cell fusion without isolation of heterokaryons or hybrids. This points out the advantage of isolating pure hybrid clones, especially when a negative result is obtained in an unsorted fusion mixture.
The enzyme deficiency in MLD was shown to be a structural mutant in which an abnormal ARSA molecule was immunologically crossreactive with normal ARSA but enzymatically deficient (27) . In MSDD, however, various hypotheses have been put forward to explain the multiple sulfatase deficiencies (11, 13) . Whatever the genetic defect is, this report has shown that it must involve a locus distinct from that responsible for MLD.
One hypothesis suggested that in MSDD a structural gene coding for a common subunit of all the deficient sulfatases was defective. If that were the case, all the residual sulfatase activities in MSDD would be due to structurally abnormal enzymes. This was not supported by recent studies which showed that the residual ARSA in MSDD was due to a reduced amount of an otherwise normal enzyme (28) and that its level can be modulated by the pH of the culture medium (29) .
Another hypothesis suggested that MSDD was due to the presence of a common inhibitor of this group of sulfatases. This was supported neither by the usual type of mixing experiments (13) nor by our results. We showed that although ARSC was deficient in the MSDD diploid parent cells, it was not at all inhibited in the MLD X MSDD hybrids.
A third hypothesis suggested that MSDD was due to a defect of a regulatory gene that controlled the level of all the sulfatases. In this case, the positive complementation of ARSA activity between MLD and MSDD cells may be interpreted as follows. In MLD, the structural gene coding for ARSA is defective but the regulator gene controlling the synthesis of all the other sulfatases is normal. Therefore, structurally normal ARSB and ARSC continue to be synthesized in normal amounts. In MSDD, the regulatory gene is defective but the structural gene coding I- for ARSA is intact. Therefore, structurally normal sulfatases were synthesized but in much reduced amounts. In the hybrids, the normal regulator gene from the MLD genome and the normal structural gene from the MSDD genome complement each other to produce ARSA molecules that are normal in structure and amount. We also noted that even in the tetraploids produced by homologous fusion of MSDD cells, ARSA, ARSB, and ARSC were generally elevated compared to the parent diploid cells. It could be argued that in the tetraploid genome of MSDD the amount of defective, or partially active, regulator gene product is now doubled, hence allowing for the increased levels of these enzymes.
Two criteria were proposed for identifying a regulatory gene mutation (30) . First, the mutation must alter the rate of enzyme synthesis or breakdown. Second, the regulatory gene locus must be separate from the structural gene locus. The intergenic complementation between MSDD and MLD has fulfilled at least the second requirement. It remains to be shown whether the first requirement will be met in the case of MSDD.
